RU2718863C2 - Способы и промежуточные соединения для получения ингибитора pde10 - Google Patents
Способы и промежуточные соединения для получения ингибитора pde10 Download PDFInfo
- Publication number
- RU2718863C2 RU2718863C2 RU2016146118A RU2016146118A RU2718863C2 RU 2718863 C2 RU2718863 C2 RU 2718863C2 RU 2016146118 A RU2016146118 A RU 2016146118A RU 2016146118 A RU2016146118 A RU 2016146118A RU 2718863 C2 RU2718863 C2 RU 2718863C2
- Authority
- RU
- Russia
- Prior art keywords
- paragraphs
- compound
- formula
- acid
- source
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/02—Lithium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/02—Magnesium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461985400P | 2014-04-28 | 2014-04-28 | |
| US61/985,400 | 2014-04-28 | ||
| PCT/US2015/027647 WO2015167969A1 (en) | 2014-04-28 | 2015-04-24 | Processes and intermediates for the preparation of a pde10 inhibitor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016146118A RU2016146118A (ru) | 2018-05-30 |
| RU2016146118A3 RU2016146118A3 (enExample) | 2018-12-24 |
| RU2718863C2 true RU2718863C2 (ru) | 2020-04-15 |
Family
ID=54359190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016146118A RU2718863C2 (ru) | 2014-04-28 | 2015-04-24 | Способы и промежуточные соединения для получения ингибитора pde10 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9650368B2 (enExample) |
| EP (1) | EP3137462B1 (enExample) |
| JP (1) | JP6474430B2 (enExample) |
| KR (1) | KR102496552B1 (enExample) |
| CN (1) | CN106459026B (enExample) |
| AU (1) | AU2015253464B2 (enExample) |
| BR (1) | BR112016025287B1 (enExample) |
| CA (1) | CA2946756C (enExample) |
| ES (1) | ES2723437T3 (enExample) |
| IL (1) | IL248585B (enExample) |
| NZ (2) | NZ716494A (enExample) |
| RU (1) | RU2718863C2 (enExample) |
| WO (1) | WO2015167969A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5674828B2 (ja) * | 2010-03-12 | 2015-02-25 | オメロス コーポレーション | Ｐｄｅ１０インヒビターならびに関連する組成物および方法 |
| NZ716462A (en) * | 2014-04-28 | 2017-11-24 | Omeros Corp | Optically active pde10 inhibitor |
| JP2018535969A (ja) | 2015-11-04 | 2018-12-06 | オメロス コーポレーション | Ｐｄｅ１０阻害剤の固体状態形態 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2012143610A (ru) * | 2010-03-12 | 2014-04-20 | Омерос Корпорейшн | Pde10 ингибиторы и содержащие их композиции и способы |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK178590D0 (da) | 1990-07-26 | 1990-07-26 | Novo Nordisk As | 1,4-disubstituerede piperaziner |
| PT100905A (pt) | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
| CA2400368A1 (en) | 1992-12-02 | 1994-06-09 | Allen J. Duplantier | Catechol diethers as selective pde iv inhibitors |
| DE4323192A1 (de) | 1993-07-10 | 1995-01-12 | Basf Ag | Verfahren zur Herstellung von Homo- und Copolymerisaten von Alk-1-enen |
| DE4325846C1 (de) | 1993-07-31 | 1995-01-19 | Herberts Gmbh | Verwendung von Furan-modifizierten aromatischen Pinakolderivaten als Initiatoren und Furan-modifizierte aromatische Pinakolderivate als solche |
| DE4343286A1 (de) | 1993-12-17 | 1995-06-22 | Hoechst Ag | Heteroaromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen |
| DE4409501A1 (de) | 1994-03-19 | 1995-09-21 | Didier Werke Ag | Verschleißfutter eines Schachtofens und Stein hierfür |
| WO1996000218A1 (en) | 1994-06-24 | 1996-01-04 | Euro-Celtique, S.A. | Compounds for and method of inhibiting phosphodiesterase iv |
| US5789434A (en) | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
| TW424087B (en) | 1995-04-06 | 2001-03-01 | Janssen Pharmaceutica Nv | 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives |
| TW332201B (en) | 1995-04-06 | 1998-05-21 | Janssen Pharmaceutica Nv | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives |
| US6037370A (en) | 1995-06-08 | 2000-03-14 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
| EP1170009B1 (en) | 1996-01-22 | 2004-04-07 | Fujisawa Pharmaceutical Co., Ltd. | Thiazolybenzofuran derivatives and their use as SRS-A and leukotiene antagonists |
| WO1998008830A1 (de) | 1996-08-26 | 1998-03-05 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Thiazol-derivate als selektive inhibitoren der pde-iv |
| JPH1087543A (ja) | 1996-09-17 | 1998-04-07 | Chisso Corp | アルコキシベンゼン誘導体、液晶組成物および液晶表示素子 |
| US6548490B1 (en) | 1997-10-28 | 2003-04-15 | Vivus, Inc. | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| WO1999045914A1 (en) | 1998-03-13 | 1999-09-16 | Maruho Kabushikikaisha | Alkyl amine derivative and local anesthetic agent using the same |
| GB9807354D0 (en) | 1998-04-07 | 1998-06-03 | Glaxo Group Ltd | Antiviral compound |
| SE9804212D0 (sv) | 1998-12-04 | 1998-12-04 | Astra Pharma Prod | Compounds |
| SK12832001A3 (sk) | 1999-03-12 | 2002-01-07 | Boehringer Ingelheim Pharmaceuticals, Inc. | Protizápalové látky, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie |
| US7141593B1 (en) | 1999-06-04 | 2006-11-28 | Abbott Laboratories | Pharmaceutical formulations |
| GB9929552D0 (en) | 1999-12-14 | 2000-02-09 | Proteus Molecular Design | Compounds |
| WO2001096334A2 (en) | 2000-06-15 | 2001-12-20 | Pharmacia Corporation | Heteroarylalkanoic acids as integrin receptor antagonists |
| US20030032579A1 (en) | 2001-04-20 | 2003-02-13 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
| YU91603A (sh) | 2001-05-22 | 2006-08-17 | Pfizer Products Inc. | Kristalni oblici azitromicina |
| EP1499662A1 (en) * | 2002-04-18 | 2005-01-26 | Avecia Limited | Prepation of a conjugated molecule and materials for use therein |
| US6821502B2 (en) | 2002-06-12 | 2004-11-23 | Chevron U.S.A. Inc. | Method of making aluminum-containing zeolite with IFR structure |
| CN1681763A (zh) | 2002-07-27 | 2005-10-12 | 阿斯特拉曾尼卡有限公司 | 化合物 |
| EA008767B1 (ru) | 2002-10-08 | 2007-08-31 | Зе Скрипс Ресеч Инститьют | Ингибиторы гидролазы амидов жирных кислот |
| ES2315546T3 (es) | 2002-10-30 | 2009-04-01 | Via Pharmaceuticals, Inc. | Inhibidores delas fosfodiesterasas de los nucleotidos ciclicos, que presentan una estructura de benzodiazepina, y su uso en terapia. |
| TW200410921A (en) | 2002-11-25 | 2004-07-01 | Hoffmann La Roche | Mandelic acid derivatives |
| AU2003289200A1 (en) | 2002-12-06 | 2004-06-30 | Kowa Co., Ltd. | Erythropoietin production accelerator |
| CA2507699A1 (en) | 2002-12-20 | 2004-07-15 | Pharmacia Corporation | Heteroarylalkanoic acids as integrin receptor antagonists |
| WO2004071509A1 (ja) | 2003-02-12 | 2004-08-26 | Nippon Chemiphar Co., Ltd. | オリゴデンドロサイト分化促進剤 |
| EP1631568A1 (en) | 2003-04-18 | 2006-03-08 | Memory Pharmaceuticals Corporation | Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| AR047541A1 (es) | 2004-02-13 | 2006-01-25 | Sandoz Ag | Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas |
| NZ550114A (en) | 2004-04-20 | 2011-02-25 | Transtech Pharma Inc | Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| EP1753428A4 (en) * | 2004-05-14 | 2010-09-15 | Abbott Lab | INHIBITORS OF KINASES AS THERAPEUTIC AGENTS |
| US7351833B2 (en) | 2004-07-23 | 2008-04-01 | Abbott Laboratories | (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
| US7449486B2 (en) * | 2004-10-19 | 2008-11-11 | Array Biopharma Inc. | Mitotic kinesin inhibitors and methods of use thereof |
| US8436176B2 (en) | 2004-12-30 | 2013-05-07 | Medicis Pharmaceutical Corporation | Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| RS51385B (sr) | 2005-01-07 | 2011-02-28 | Pfizer Products Inc. | Heteroaromatična jedinjenja hinolina i njihova upotreba kao pde10 inhibitora |
| EP1850681B1 (en) | 2005-02-04 | 2019-12-18 | Firmenich Incorporated | Compounds comprising linked hetero aryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
| US20060252807A1 (en) | 2005-04-22 | 2006-11-09 | Kalypsys, Inc. | Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders |
| UA91546C2 (uk) | 2005-05-03 | 2010-08-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ |
| MY152185A (en) | 2005-06-10 | 2014-08-29 | Novartis Ag | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| US20070032531A1 (en) | 2005-08-04 | 2007-02-08 | Apogee Biotechnology Corporation | Sphingosine kinase inhibitors and methods of their use |
| KR20080050577A (ko) | 2005-08-29 | 2008-06-09 | 사노피-아벤티스 유.에스. 엘엘씨 | 피리다지노[4,5-ｂ]인돌 유도체의 신규 결정질 형태 |
| EP2119723A1 (en) | 2005-09-13 | 2009-11-18 | Sicor, Inc. | Processes for the synthesis of rocuronium bromide |
| US8637559B2 (en) | 2005-11-15 | 2014-01-28 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound and pharmaceutical composition |
| AU2006327316A1 (en) | 2005-12-23 | 2007-06-28 | Astrazeneca Ab | Imidazoles as GABA-B receptor modulators |
| JP2009535394A (ja) | 2006-05-02 | 2009-10-01 | ファイザー・プロダクツ・インク | Ｐｄｅ１０阻害剤としての二環式ヘテロアリール化合物 |
| US20080090834A1 (en) | 2006-07-06 | 2008-04-17 | Pfizer Inc | Selective azole pde10a inhibitor compounds |
| EP2059234B1 (en) | 2006-09-08 | 2011-11-02 | Ore Pharmaceuticals Inc. | Method for reducing or alleviating inflammation in the digestive tract |
| MX2009003160A (es) | 2006-09-25 | 2009-04-06 | Ptc Therapeutics Inc | Formas cristalinas del acido 3-[5-(2-fluorofenil)-[1,2,4]oxadiazol -3-il]-benzoico. |
| AU2007300532A1 (en) | 2006-09-28 | 2008-04-03 | Merck Sharp & Dohme Corp. | Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitor chelate complexes |
| WO2008040669A2 (en) | 2006-10-02 | 2008-04-10 | Janssen Pharmaceutica N.V. | Novel intermediates for the preparation of a glyt1 inhibitor |
| US7837978B2 (en) | 2006-10-13 | 2010-11-23 | Chevron U.S.A. Inc. | Process for preparing aluminum-containing molecular sieve SSZ-26 |
| ES2624791T3 (es) * | 2006-11-21 | 2017-07-17 | Omeros Corporation | Inhibidores de PDE10 y composiciones y métodos relacionados |
| US7786139B2 (en) * | 2006-11-21 | 2010-08-31 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
| PE20081506A1 (es) | 2006-12-12 | 2008-12-09 | Infinity Discovery Inc | Formulaciones de ansamicina |
| WO2009008906A2 (en) | 2007-02-06 | 2009-01-15 | The Trustees Of The University Of Pennsylvania | Therapeutic compounds for blocking dna synthesis of pox viruses |
| AU2008253803A1 (en) | 2007-05-22 | 2008-11-27 | Ultimorphix Technolgies B.V. | Tenofovir disoproxil hemi-fumaric acid Co-crystal |
| EP2017264A1 (de) | 2007-07-16 | 2009-01-21 | Bayer Cropscience Ag | Substituierte Phenylpropargylverbindungen, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| WO2009049022A1 (en) | 2007-10-10 | 2009-04-16 | Ore Pharmaceuticals Inc. | Method for treatment of pancreatitis |
| TW200944520A (en) | 2008-01-29 | 2009-11-01 | Glaxo Group Ltd | Spiro compounds as NPY Y5 receptor antagonists |
| WO2009143178A2 (en) | 2008-05-20 | 2009-11-26 | Omeros Corporation | Pde10 inhibitors and related compositions and methods |
| TWI501965B (zh) | 2008-06-20 | 2015-10-01 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物 |
| EP2310016B1 (en) * | 2008-08-05 | 2017-10-04 | Omeros Corporation | Pde10 inhibitors and related compositions and methods |
| NZ716462A (en) * | 2014-04-28 | 2017-11-24 | Omeros Corp | Optically active pde10 inhibitor |
-
2014
- 2014-09-10 NZ NZ716494A patent/NZ716494A/en unknown
- 2014-09-10 NZ NZ630810A patent/NZ630810A/en unknown
-
2015
- 2015-04-24 WO PCT/US2015/027647 patent/WO2015167969A1/en not_active Ceased
- 2015-04-24 AU AU2015253464A patent/AU2015253464B2/en active Active
- 2015-04-24 CA CA2946756A patent/CA2946756C/en active Active
- 2015-04-24 KR KR1020167032983A patent/KR102496552B1/ko active Active
- 2015-04-24 JP JP2016564031A patent/JP6474430B2/ja active Active
- 2015-04-24 RU RU2016146118A patent/RU2718863C2/ru active
- 2015-04-24 CN CN201580023525.XA patent/CN106459026B/zh active Active
- 2015-04-24 EP EP15785376.3A patent/EP3137462B1/en active Active
- 2015-04-24 BR BR112016025287-0A patent/BR112016025287B1/pt active IP Right Grant
- 2015-04-24 ES ES15785376T patent/ES2723437T3/es active Active
- 2015-04-24 US US14/696,287 patent/US9650368B2/en active Active
-
2016
- 2016-10-27 IL IL248585A patent/IL248585B/en active IP Right Grant
-
2017
- 2017-04-07 US US15/482,604 patent/US20180057484A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2012143610A (ru) * | 2010-03-12 | 2014-04-20 | Омерос Корпорейшн | Pde10 ингибиторы и содержащие их композиции и способы |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2016146118A (ru) | 2018-05-30 |
| NZ630810A (en) | 2016-03-31 |
| EP3137462A1 (en) | 2017-03-08 |
| AU2015253464B2 (en) | 2018-11-22 |
| JP6474430B2 (ja) | 2019-02-27 |
| KR102496552B1 (ko) | 2023-02-06 |
| CN106459026A (zh) | 2017-02-22 |
| JP2017513885A (ja) | 2017-06-01 |
| US9650368B2 (en) | 2017-05-16 |
| CA2946756C (en) | 2022-03-29 |
| ES2723437T3 (es) | 2019-08-27 |
| NZ716494A (en) | 2017-07-28 |
| AU2015253464A1 (en) | 2016-10-27 |
| US20160024069A1 (en) | 2016-01-28 |
| KR20160147275A (ko) | 2016-12-22 |
| EP3137462A4 (en) | 2017-12-27 |
| IL248585A0 (en) | 2016-12-29 |
| EP3137462B1 (en) | 2019-01-30 |
| BR112016025287B1 (pt) | 2022-10-11 |
| US20180057484A1 (en) | 2018-03-01 |
| WO2015167969A1 (en) | 2015-11-05 |
| BR112016025287A2 (pt) | 2017-08-15 |
| CA2946756A1 (en) | 2015-11-05 |
| CN106459026B (zh) | 2019-07-05 |
| RU2016146118A3 (enExample) | 2018-12-24 |
| IL248585B (en) | 2020-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2557465T3 (es) | Moduladores de la actividad de HEC 1 y procedimientos para ello | |
| RS57569B1 (sr) | Postupci za pripremanje agensa koji uzrokuje apoptozu | |
| KR20130129180A (ko) | 아미노벤조일벤조푸란 유도체의 제조 방법 | |
| CA3108974A1 (en) | Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof | |
| KR20160097230A (ko) | 바이사이클릭 알킬 화합물 및 합성 | |
| KR20170016894A (ko) | 1,3-벤조디옥솔 헤테로사이클릭 화합물의 제조 방법 | |
| RU2718863C2 (ru) | Способы и промежуточные соединения для получения ингибитора pde10 | |
| JP2024037802A (ja) | （ｓ）－ｔｅｒｔ－ブチル４，５－ジアミノ－５－オキソペンタノエートの調製プロセス | |
| JP2021502376A (ja) | ベンゾフラン誘導体の製造方法 | |
| JP2017513913A (ja) | 光学活性なｐｄｅ１０阻害剤 | |
| JP2007532694A (ja) | マイクロ波を利用したグリコールウリル及びククルビツリルの製造方法 | |
| KR20200144546A (ko) | 피롤로아미노피리다지논 화합물 및 이의 중간체의 제조 방법 | |
| WO2010098496A1 (en) | Process for producing tetrahydrotriazolopyridine derivative | |
| CN104710417A (zh) | 氮杂吲哚类衍生物及其合成方法 | |
| Shi et al. | An efficient and green synthesis of 3, 3′‐benzylidenebis (4‐hydroxy‐6‐methylpyridin‐2 (1H)‐one) derivatives through multi‐component reaction in ionic liquid | |
| An et al. | Efficient formation of C–S bond using heterocyclic thiones and arynes | |
| JP6067700B2 (ja) | アルコール酸化触媒及びそれを用いたアルコール酸化方法 | |
| Zali-Boeini et al. | One-step synthesis of imidazo [1, 2-a] pyridines in water | |
| WO2008155745A2 (en) | New process for the manufacture of 1h-imidazo[4,5-c]-quinoline ring systems | |
| KR20170080190A (ko) | 1,5-쌍극자의 [5+3] 고리화 첨가 반응을 이용한 8원 헤테로 고리 화합물의 제조 방법 및 이에 의해 제조된 8원 헤테로 고리 화합물 | |
| KR100902236B1 (ko) | 펜에틸 벤조에이트 유도체 및 그의 제조방법 | |
| JPWO2005085204A1 (ja) | 含窒素５員環化合物の製造方法 | |
| JP2001252569A (ja) | 高分子固定化キラルジルコニウム触媒 | |
| WO2025240628A1 (en) | Processes for preparing a pkc inhibitor | |
| CN111704571A (zh) | 光学活性2-芳基螺环[环戊烷-1,3’-吲哚]-3-甲醛的制备方法 |